Pages tagged “NIDA”
-
ACS – MCRAA Joint Comments on FDA Proposed Research Guidelines
The Medical Cannabis Research Advocacy Alliance (MCRAA) appreciates the opportunity to provide comments in response to the US Food and Drug Administration (FDA)’s Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Draft Guidance for Industry; Availability 85 FR 44305 (July 22, 2020).
Written by Jordan Tishler
February 25, 2024 -
National Institute on Drug Abuse Turns 50
“And even if medical science has changed its views on addiction, policies and social structures have been slower in following the science toward a public health-based approach.” - Dr. Nora Volkow, President of NIDA
Written by Kelsey Engvik
February 07, 2024